Therapeutic applications of lipid-coated microbubbles

Advanced Drug Delivery Reviews

Volumn 56, Issue 9, 2004, Pages 1291-1314

  Unger, Evan C ^a,b   Porter, Thomas ^c   Culp, William ^d   Labell, Rachel ^a   Matsunaga, Terry ^a   Zutshi, Reena ^a  

^a ImaRx Therapeutics Inc   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^d UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Blood brain barrier; Cavitation; Clot lysis; Drug delivery; Emulsions; Gene delivery; Lipid; Microbubbles; Microspheres; Perfluorocarbon; Sonothrombolysis; Ultrasound

Indexed keywords

BLOOD VESSELS; COATINGS; EMULSIONS; GENES; LIPIDS; MOLECULAR WEIGHT; NEUROLOGY;

GENE DELIVERY; LIPID COATINGS; MICROBUBBLES; NANOEMULSIONS;

DRUG PRODUCTS;

FLUOROCARBON;

BLOOD BRAIN BARRIER; DIAGNOSTIC IMAGING; DRUG TARGETING; ECHOGRAPHY; GENE TARGETING; MATERIAL COATING; MICROVASCULATURE; MOLECULAR DYNAMICS; MOLECULAR WEIGHT; PRIORITY JOURNAL; REVIEW;

EID: 1942486333     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addr.2003.12.006     Document Type: Article

References (123)

1. Apfel R.E., Holland C.K. Gauging the likelihood of cavitation from short-pulse, low-duty cycle diagnostic ultrasound. Ultrasound Med. Biol. 17:1991;179-185.
2. Crum L.A., Roy R.A., Dinno M.A., Church C.C., Apfel R.E., Holland C.K., Madanshetty S.I. Acoustic cavitation produced by microsecond pulses of ultrasound: a discussion of some selected results. J. Acoust. Soc. Am. 91:1992;1113-1119.
3. Chin C.T., Burns P.N. Predicting the acoustic response of a microbubble population for contrast imaging in medical ultrasound. Ultrasound Med. Biol. 26:2000;1293-1300.
4. Tiemann K., Lohmeier S., Kuntz S., Koster J., Pohl C., Burns P., Nanda N.C., Luderitz B., Becter H. Real-time contrast echo assessment of myocardial perfusion at low emission power: first experimental and clinical result using power pulse inversion imaging. Echocardiography. 16:1999;799-809.
5. Fritz T., McKeon M., Unger E. Preclinical studies of MRX-115: safety evaluations of a myocardial perfusion agent. Acad. Radiol. 3:1996;S185-S187.
6. Fritz T., McKeon M., Unger E. Preclinical studies of MRX-115 (Aerosomes®): safety evaluation of a new myocardial perfusion contrast agent. CMR. 95:1995;17-22. (Naantali, Finland, June).
7. Grauer S.E., Sutherland G., Fritz T. Safety and echo contrast efficacy of multiple doses of Aerosomes MRX-115 in a phase I clinical trial. AHA, 69th Scientific Sessions, New Orleans, Louisianna, November 10-13, 1996. Circulation. vol. 94:1996;I316-I319. I-316-319, Abs #1857.
8. Lindner J.R., Song J., Jayaweera A.R., Sklenar J., Kaul S. Microvascular rheology of Definity microbubbles after intra-arterial and intravenous administration. J. Am. Soc. Echocardiogr. 15:2002;396-403.
9. Choi D., Lim H.K., Kim S.H., Lee W.J., Jang H.J., Lee J.Y., Paik S.W., Koh K.C., Lee J.H. Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: usefulness of power Doppler US with a microbubble contrast agent in evaluating therapeutic response - preliminary results. Radiology. 217:2000;558-563.
10. Solbiati L., Goldberg S.N., Ierace T., Dellanoce M., Livraghi T., Gazelle G.S. Radio-frequency ablation of hepatic metastases: postprocedural assessment with a US microbubble contrast agent - early experience. Radiology. 211:1999;643-649.
11. Oshowo A., Gillams A.R., Lees W.R., Taylor I. Radiofrequency ablation extends the scope of surgery in colorectal liver metastases. Eur. J. Surg. Oncol. 29:2003;244-247.
12. Komorizono Y., Oketani M., Sako K., Yamasaki N., Shibatou T., Maeda M., Kohara K., Shigenobu S., Ishibashi K., Arima T. Risk factors for local recurrence of small hepatocellular carcinoma tumors after a single session, single application of percutaneous radiofrequency ablation. Cancer. 97:2003;1253-1262.
13. Hohmann J., Albrecht T., Hoffmann C.W., Wolf K.J. Ultrasonographic detection of focal liver lesions: increased sensitivity and specificity with microbubble contrast agents. Eur. J. Radiol. 46:2003;147-159.
14. Harvey C.J., Kim A.K., Blomley M.J., Taylor-Robinson S.D., Gedroyc W.M., Cosgrove D.O. Detection of an occult hepatocellular carcinoma using ultrasound with liver-specific microbubbles. Eur. Radiol. 12:2002;S70-S73. (Suppl).
15. Barr R. ATL/Philips Ultrasound, Seeking consensus: contrast ultrasound in radiology. Eur. J. Radiol. 41:2002;207-216.
16. Porter T.R., Xie F. Ultrasound, microbubbles, and thrombolysis. Prog. Cardiovasc. Dis. 44:2001;101-110.
17. Porter T.R., LeVeen R.F., Fox R., Kricsfeld A., Xie F. Thrombolytic enhancement with perfluorocarbon-exposed sonicated dextrose albumin microbubbles. Am. Heart J. 132:1996;964-968.
18. Porter T.R., Kricsfeld D., Lof J., Everbach E.C., Xie F. Effectiveness of transcranial and transthoracic ultrasound and microbubbles in dissolving intravascular thrombi. J. Ultrasound Med. 20:2001;1313-1325.
19. Culp W.C., Porter T.R., Xie F., Goertzen T.C., McCowan T.C., Vonk B.N., Baxter B.T. Microbubble potentiated ultrasound as a method of declotting thrombosed dialysis grafts: experimental study in dogs. Cardiovasc. Interv. Radiol. 24:2001;407-412.
20. Culp W.C., Porter T.R., McCowan T.C., Roberson P.K., James C.A., Matchett W.J., Moursi M. Microbubble-augmented ultrasound declotting of thrombosed arteriovenous dialysis grafts in dogs. J. Vasc. Interv. Radiol. 14:2003;343-347.
21. Birnbaum Y., Luo H., Nagai T., Fishbein M.C., Peterson T.M., Li S., Kricfeld D., Porter T.R., Siegel R.J. Noninvasive in vivo clot dissolution without a thrombolytic drug: recanalization of thrombosed iliofemoral arteries by transcutaneous ultrasound combined with intravenous infusion of microbubbles. Circulation. 97:1998;130-134.
22. Suchkova V.N., Baggs R.B., Francis C.W. Effect of 40 kHz ultrasound on acute thrombotic ischemia in a rabbit femoral artery thrombosis model: enhancement of thrombolysis and improvement in capillary muscle perfusion. Circulation. 101:2000;2296-2301.
23. Everbach E.C., Francis C.W. Cavitational mechanisms in ultrasound-accelerated thrombolysis at 1 MHz. Ultrasound Med. Biol. 26:2000;1153-1160.
24. Francis C.W. Ultrasound-enhanced thrombolysis. Echocardiography. 18:2001;239-246.
25. Siegel R.J., Atar S., Fishbein M.C., Brasch A.V., Peterson T.M., Nagai T., Pal D., Nishioka T., Chae J., Birnbaum Y., Zanelli C., Luo H. Noninvasive transcutaneous low frequency ultrasound enhances thrombolysis in peripheral and coronary arteries. Echocardiography. 18:2001;247-257.
26. Dhond M.R., Nguyen T.T., Dolan C., Pulido G., Bommer W.J. Ultrasound-enhanced thrombolysis at 20 kHz with air-filled and perfluorocarbon-filled contrast biospheres. J. Am. Soc. Echocardiogr. 13:2000;1025-1029.
27. Hynynen K., McDannold N., Vykhodtseva N., Jolesz F. Noninvasive MR imaging-guided focal opening of the blood-brain barrier in rabbits. Radiology. 220:2001;640-646.
28. Mesiwala A.H., Mourad P.D. Monitoring of biologic effects of focused ultrasound beams on the brain. Radiology. 224:2002;294-296. (author reply 296-297).
29. Mesiwala A.H., Farrell L., Wenzel H.J., Silbergeld D.L., Crum L.A., Winn H.R., Mourad P.D. High-intensity focused ultrasound selectively disrupts the blood-brain barrier in vivo. Ultrasound Med. Biol. 28:2002;389-400.
30. Unger E.C., Matsunaga T.O., McCreery T., Schumann P., Sweitzer R., Quigley R. Therapeutic applications of microbubbles. Eur. J. Radiol. 42:2002;160-168.
31. Unger E.C., Hersh E., Vannan M., Matsunaga T.O., McCreery T. Local drug and gene delivery through microbubbles. Prog. Cardiovasc. Dis. 44:2001;45-54.
32. Allen J.S., May D.J., Ferrara K.W. Dynamics of therapeutic ultrasound contrast agents. Ultrasound Med. Biol. 28:2002;805-816.
33. Miura S., Tachibana K., Okamoto T., Saku K. In vitro transfer of antisense oligodeoxynucleotides into coronary endothelial cells by ultrasound. Biochem. Biophys. Res. Commun. 298:2002;587-590.
34. Taniyama Y., Tachibana K., Hiraoka K., Aoki M., Yamamoto S., Matsumoto K., Nakamura T., Ogihara T., Kaneda Y., Morishita R. Development of safe and efficient novel nonviral gene transfer using ultrasound: enhancement of transfection efficiency of naked plasmid DNA in skeletal muscle. Gene Ther. 9:2002;372-380.
35. Greenleaf W.J., Bolander M.E., Sarkar G., Goldring M.B., Greenleaf J.F. Artificial cavitation nuclei significantly enhance acoustically induced cell transfection. Ultrasound Med. Biol. 24:1998;587-595.
36. Miller D.L., Pislaru S.V., Greenleaf J.E. Sonoporation: mechanical DNA delivery by ultrasonic cavitation. Somat. Cell Mol. Genet. 27:2002;115-134.
37. Porter T.R., Xie F. Therapeutic ultrasound for gene delivery. Echocardiography. 18:2001;349-353.
38. Lu Q.L., Liang H.D., Partridge T., Blomley M.J. Microbubble ultrasound improves the efficiency of gene transduction in skeletal muscle in vivo with reduced tissue damage. Gene Ther. 10:2003;396-405.
39. Teupe C., Richter S., Fisslthaler B., Randriamboavonjy V., Ihling C., Fleming I., Busse R., Zeiher A.M., Dimmeler S. Vascular gene transfer of phosphomimetic endothelial nitric oxide synthase (S1177D) using ultrasound-enhanced destruction of plasmid-loaded microbubbles improves vasoreactivity. Circulation. 105:2002;1104-1109.
40. Shohet R.V., Chen S., Zhou Y.T., Wang Z., Meidell R.S., Unger R.H., Grayburn P.A. Echocardiographic destruction of albumin microbubbles directs gene delivery to the myocardium. Circulation. 101:2000;2554-2556.
41. Anwer K., Kao G., Proctor B., Anscombe I., Florack V., Earls R., Wilson E., McCreery T., Unger E., Rolland A., Sullivan S.M. Ultrasound enhancement of cationic lipid-mediated gene transfer to primary tumors following systemic administration. Gene Ther. 7:2000;1833-1839.
42. Unger E.C., Hersh E., Vannan M., McCreery T. Gene delivery using ultrasound contrast agents. Echocardiography. 18:2001;355-361.
43. Vannan M., McCreery T., Li P., Han Z., Unger E., Kuersten B., Nabel E., Rajagopalan S. Ultrasound-mediated transfection of canine myocardium by intravenous administration of cationic microbubble-linked plasmid DNA. J. Am. Soc. Echocardiogr. 15:2002;214-218.
44. Unger E.C., McCreery T., Sweitzer R.H. Ultrasound enhances gene expression of liposomal transfection. Invest. Radiol. 32:1997;723-727.
45. Wu Y., Unger E.C., McCreery T.P., Sweitzer R.H., Shen D., Wu G., Vielhauer M.D. Binding and lysing of blood clots using MRX-408. Invest. Radiol. 33:1998;880-885.
46. Linder J.R., Song J.et al. Noninvasive ultrasound imaging of inflammation using microbubbles targeted to activated leukocytes. Circulation. 102:2000;2745-2750.
47. Linder J.R. Evolving applications for contrast ultrasound. Am. J. Cardiol. 90:2002;72J-80J.
48. Schumann P.A., Christiansen J.P., Quigley R.M., McCreery T.P., Sweizter R.H., Unger E.C., Lindner J.R., Matsunaga T.O. Targeted-microbubble binding selectively to GPIIb IIIa receptors of platelet thrombi. Invest. Radiol. 37:2002;587-593.
49. Klibanov A.L. Targeted delivery of gas-filled microspheres, contrast agents for ultrasound imaging. Adv. Drug Deliv. Rev. 37:1999;139-157.
50. Weiss D.J., Strandjord T.P., Liggitt D., Clark J.G. Perflubron enhances adenovirus-mediated gene expression in lungs of transgenic mice with chronic alveolar filling. Hum. Gene Ther. 10:1999;2287-2293.
51. Weiss D.J., Baskin G.B., Shean M.K., Blanchard J.L., Kolls J.K. Use of perflubron to enhance lung gene expression: safety and initial efficacy studies in non-human primates. Molec. Ther. 5:2002;8-15.
52. Unger E.C., McCreery T.P., Sweitzer R.H., Caldwell V.E., Wu Y. Acoustically active lipospheres containing paclitaxel: a new therapeutic ultrasound contrast agent. Invest. Radiol. 12:1998;886-892.
53. Lanza G.M., Wickline S.A. Targeted ultrasonic contrast agents for molecular imaging and therapy. Prog. Cardiovasc. Dis. 44:2001;13-31.
54. Nishioka T., Luo H., Fishbein M.C., Cercek B., Forrester J.S., Kim C., Berglund H., Siegel R.J. Dissolution of thrombotic arterial occlusion by high intensity, low frequency ultrasound and dodecafluoropentane emulsion: an in vitro and in vivo study. J. Am. Coll. Cardiol. 30:1997;561-568.
55. E.C. Unger, Novel prodrugs compromising fluorinated amphiphiles, US Patent 6,028,066, 2000.
56. Van Liew H.D., Burkard M.E. High oxygen partial pressure in tissue delivered by stabilized microbubbles: theory. Adv. Exp. Med. Biol. 411:1997;395-401.
57. Van Liew H.D., Burkard M.E. Relationship of oxygen content to PO2 for stabilized bubbles in the circulation: theory. J. Appl. Physiol. 81:1996;500-508.
58. Burkard M.E., Van Liew H.D. Oxygen transport to tissue by persistent bubbles: theory and simulations. J. Appl. Physiol. 77:1994;2874-2878.
59. E.C. Unger, T. McCreery, Y. Wu, Oxygen delivery agents and uses for the same, US Patent 6,537,246, 2003.
60. Dohrmann G.J., Rubin J.M. History of intraoperative ultrasound in neurosurgery. Neurosurg. Clin. N. Am. 12:2001;155-166.
61. Wells P.N. Advances in ultrasound: from microscanning to telerobotics. Br. J. Radiol. 73:2000;1138-1147.
62. Darkazanli A., Hynynen K., Unger E.C., Schenck J.F. On-line monitoring of ultrasonic surgery with MR imaging. J. Magn. Reson. Imaging. 3:1993;509-514.
63. Harvey C.J., Pilcher J.M., Eckersley R.J., Blomley M.J., Cosgrove D.O. Advances in ultrasound. Clin. Radiol. 57:2002;157-177.
64. Gertz E.W., Manspeaker H.P., Fritz T.A., Kaul S., Unger E.C. Aerosomes® myocardial contrast echocardiography (MCE) accurately detects resting myocardial perfusion abnormalities post myocardial infarction. Ultrasound Med. Biol. 23:1997;23.
65. E.C. Unger, T.A. Fritz, Phase I/II clinical trials of MRX-115 - a new ultrasound contrast agent, AIUM, San Diego, CA, March 23-26, 1997.
66. Janzen N., Zisman A., Pantuck A.J., Perry K., Schulam P., Belldegrun A.S. Minimally invasive ablative approaches in the treatment of renal cell carcinoma. Curr. Urol. Rep. 3:2002;13-20.
67. Miller D.L., Song J. Tumor growth reduction and DNA transfer by cavitation-enhanced high-intensity focused ultrasound in vivo. Ultrasound Med. Biol. 29:2003;887-893.
68. Kohrmann K.U., Michel M.S., Steidler A., Marlinghaus E., Kraut O., Alken P. Technical characterization of an ultrasound source for noninvasive thermoablation by high-intensity focused ultrasound. BJU Int. 90:2002;248-252.
69. Wu F., Chen W.Z., Bai J., Zou J.Z., Wang Z.L., Zhu H., Wang Z.B. Tumor vessel destruction resulting from high-intensity focused ultrasound in patients with solid malignancies. Ultrasound Med. Biol. 28:2002;535-542.
70. ter Haar G.R. High intensity focused ultrasound for the treatment of tumors. Echocardiography. 18:2001;317-322.
71. Erce C., Parks R.W. Interstitial ablative techniques for hepatic tumours. Br. J. Surg. 90:2003;272-289.
72. Hilgenfeldt S., Lohse D., Zomack M. Sound scattering and localized heat deposition of pulse-driven microbubbles. J. Acoust. Soc. Am. 107:2000;3530-3539.
73. American Heart Association Heart Disease and Stroke Statistics - 2003, Update. 2002;AHA, Dallas, TX.
74. Hirsh J., Hoak J., American Heart Association Management of deep vein thrombosis and pulmonary embolism. A statement for healthcare professionals from the council on thrombosis. Circulation. 93:1996;2212-2245. ( http: //www.americanheart.org/presenter.jhtml?identifier=1482 ).
75. http://www.spotlighthealth.com/dvt/dvt_overview/dvtstatistics.html.
76. Tachibana K., Tachibana S. The use of ultrasound for drug delivery. Echocardiography. 18:2001;323-328.
77. Unger E.C., McCreery T., Sweitzer R., Vielhauer G., Wu G., Shen D., Yellowhair D. MRX-501: a novel ultrasound contrast agent with therapeutic properties. Acad. Radiol. Suppl 1:1998;S247-S249.
78. Buddemeyer E.U. The physics of diagnostic ultrasound. Radiol. Clin. North Am. 13:1975;391-402.
79. Awasthi V.D., Garcia D., Goins B.A., Phillips W.T. Circulation and biodistribution profiles of long-circulating PEG-liposomes of various sizes in rabbits. Int. J. Pharm. 2003;121-132.
80. Zeisig R., Shimada K., Hirota S., Arndt D. Effect of sterical stabilization on macrophage uptake in vitro and on thickness of the fixed aqueous layer of liposomes made from alkylphosphocholines. Biochim. Biophys. Acta. 1996;237-245.
81. Gaur U., Sahoo S.K., De T.K., Ghosh P.C., Maitra A., Ghosh P.K. Biodistribution of fluoresceinated dextran using novel nanoparticles evading reticuloendothelial system. Int. J. Pharm. 2000;1-10.
82. Chomas J.E., Dayton P., May D., Ferrara K. Threshold of fragmentation for ultrasonic contrast agents. J. Biomed. Opt. 2001;141-150.
83. Mallarde D., Boutignon F., Moine F., Barre E., David S., Touchet H., Ferruti P., Deghenghi R. PLGA-PEG microspheres of teverelix: influence of polymer type on microsphere characteristics and on teverelix in vitro release. Int. J. Pharm. 2003;69-80.
84. Capan Y., Jiang G., Giovagnoli S., Na K.H., DeLuca P.P. Preparation and characterization of poly(D, L-lactide-co-glycolide) microspheres for controlled release of human growth hormone. AAPS PharmSciTech. 2003;E28.
85. Berkland C., Kim K., Pack D.W. Fabrication of PLG microspheres with precisely controlled and monodisperse size distributions. J. Control. Release. 2001;59-74.
86. Song J., Qi M., Kaul S., Price R.J. Stimulation of arteriogenesis in skeletal muscle by microbubble destruction with ultrasound. Circulation. 2002;1550-1555.
87. Skyba D.M., Price R.J., Linka A.Z., Skalak T.C., Kaul S. Direct in vivo visualization of intravascular destruction of microbubbles by ultrasound and its local effects on tissue. Circulation. 1998;290-293.
88. Dayton P.A., Chomas J.E., Lum A.F., Allen J.S., Lindner J.R., Simon S.I., Ferrara K.W. Optical and acoustical dynamics of microbubble contrast agents inside neutrophils. Biophys. J. 80:2001;1547-1556.
89. Taniyama Y., Tachibana K., Hiraoka K., Namba T., Yamasaki K., Hashiya N., Aoki M., Ogihara T., Yasufumi K., Morishita R. Local delivery of plasmid DNA into rat carotid artery using ultrasound. Circulation. 105:2002;1233-1239.
90. Lawrie A., Brisken A.F., Francis S.E., Tayler D.I., Chamberlain J., Crossman D.C., Cumberland D.C., Newman C.M. Ultrasound enhances reporter gene expression after transfection of vascular cells in vitro. Circulation. 99:1999;2617-2620.
91. Newman C.M., Lawrie A., Brisken A.F., Cumberland D.C. Ultrasound gene therapy: on the road from concept to reality. Echocardiography. 18:2001;339-347.
92. Amabile P.G., Waugh J.M., Lewis T.N., Elkins C.J., Janas W., Dake M.D. High-efficiency endovascular gene delivery via therapeutic ultrasound. J. Am. Coll. Cardiol. 37:2001;1975-1980.
93. Hosseinkhani H., Aoyama T., Ogawa O., Tabata Y. Ultrasound enhances the transfection of plasmid DNA by non-viral vectors. Curr. Pharm. Biotechnol. 4:2003;109-122.
94. Anwer K., Meaney C., Kao G., Hussain N., Shelvin R., Earls R.M., Leonard P., Quezada A., Rolland A.P., Sullivan S.M. Cationic lipid-based delivery system for systemic cancer gene therapy. Cancer Gene Ther. 7:2000;1156-1164.
95. Takeuchi M., Ogunyankin K., Pandian N.G., McCreery T.P., Sweitzer R.H., Caldwell V.E., Unger E.C., Avelar E., Sheahan M., Connolly R. Enhanced visualization of intravascular and left atrial appendage thrombus with the use of a thrombus-targeting ultrasonographic contrast agent (MRX-408A1): in vivo experimental echocardiographic studies. J. Am. Soc. Echocardiogr. 12:1999;1015-1021.
96. Callahan M.K., Williamson P., Schlegel R.A. Surface expression of phosphatidylserine on macrophages is required for phagocytosis of apoptotic thymocytes. Cell Death Differ. 2000;645-653.
97. Fadok V.A., de Cathelineau A., Daleke D.L., Henson P.M., Bratton D.L. Loss of phospholipid asymmetry and surface exposure of phosphatidylserine is required for phagocytosis of apoptotic cells by macrophages and fibroblasts. J. Biol. Chem. 2001;1071-1077.
98. Lechardeur D., Lukacs G.L. Intracellular barriers to non-viral gene transfer. Curr. Gene Ther. 2002;183-194.
99. Meyer F., Finer M. Gene therapy: progress and challenges. Cell. Mol. Biol. 2001;1277-1294.
100. Brown M.D., Schatzlein A.G., Uchegbu I.F. Gene delivery with synthetic (non-viral) carriers. Int. J. Pharm. 2001;1-21.
101. Rubanyi G.M. The future of human gene therapy. Mol. Aspects Med. 2001;113-142.
102. Woodle M.C. Surface-modified liposomes: assessment and characterization for increased stability and prolonged blood circulation. Chem. Phys. Lipids. 64:1993;249-262.
103. Woodle M.C., Lasic D.D. Sterically stabilized liposomes. Biochim. Biophys. Acta. 1113:1992;171-199.
104. Needham D., McIntosh T.J., Lasic D.D. Repulsive interactions and mechanical stability of polymer-grafted lipid membranes. Biochim. Biophys. Acta. 1108:1992;40-48.
105. Winter P.M., Caruthers S.D., Kassner A., Harris T.D., Chinen L.K., Allen J.S., Lacy E.K., Zhang H., Robertson J.D., Wickline S.A., Lanza G.M. Molecular imaging of angiogenesis in nascent Vx-2 rabbit tumors using a novel alpha(nu)beta3-targeted nanoparticle and 1.5 tesla magnetic resonance imaging. Cancer Res. 2003;5838-5843.
106. Marsh J.N., Hall C.S., Wickline S.A., Lanza G.M. Temperature dependence of acoustic impedance for specific fluorocarbon liquids. J. Acoust. Soc. Am. 2002;2858-2862.
107. Marsh J.N., Hall C.S., Scott M.J., Fuhrhop R.W., Gaffney P.J., Wickline S.A., Lanza G.M. Improvements in the ultrasonic contrast of targeted perfluorocarbon nanoparticles using an acoustic transmission line model. IEEE Trans. Ultrason. Ferroelectr. Freq. Control. 2002;29-38.
108. http://www.lungusa.org/diseases/.
109. Groneberg D.A., Witt C., Wagner U., Chung K.F., Fischer A. Fundamentals of pulmonary drug delivery. Respir. Med. 97:2003;382-387.
110. Gumbleton M. Caveolae as potential macromolecule trafficking compartments within alveolar epithelium. Adv. Drug Deliv. Rev. 49:2001;281-300.
111. Thompson P.J. Drug delivery to the small airways. Am. J. Respir. Crit. Care Med. 157:1998;S199-202.
112. Newhouse M.T. Tennis anyone? The lungs as a new court for systemic therapy. Can. Med. Assoc. J. 161:1999;1287-1288.
113. Edwards D.A., Hanes J., Caponetti G., Hrkach J., Ben-Jebria A., Eskew M.L., Mintzes J., Deaver D., Lotan N., Langer R. Large porous particles for pulmonary drug delivery. Science. 276:1997;1868-1871.
114. Musante C.J., Schroeter J.D., Rosati J.A., Crowder T.M., Hickey A.J., Martonen T.B. Factors affecting the deposition of inhaled porous drugs. J. Pharm. Sci. 91:2002;1590-1600.
115. Edwards D.A., Ben-Jebria A., Langer R. Recent advances in pulmonary drug delivery using large, porous inhaled particles. J. Appl. Physiol. 85:1998;379-385.
116. http://www.allp.com/.
117. Cuignet O.Y., Baele P.M., Van Obbergh L.J. A second-generation blood substitute (perflubron emulsion) increases the blood solubility of modern volatile anesthetics in vitro. Anesth. Analg. 95:2002;368-372.
118. Nakamura T., Tamura M. Partial liquid ventilation with low dose of perflubron and a low stretch ventilation strategy improves oxygenation in a rabbit model of surfactant depletion. Biol. Neonate. 82:2002;66-69.
119. Schlosser R.L., Veldman A., Fischer D., Funk B., Brand J., von Loewenich V. Comparison of effects of perflubron and surfactant lung lavage on pulmonary gas exchange in a piglet model of meconium aspiration. Biol. Neonate. 81:2002;126-131.
120. Doctor A., Price B., Bhargava N., DiCanzio J., Arnold J.H. High-frequency oscillatory ventilation of the perfluorocarbon-filled lung: dose-response relationships in an animal model of acute lung injury. Crit. Care Med. 29:2001;847-854.
121. Liu J.-B., Goldberg B.B., Merton D.A., Rawool N.M., Needleman L., Forsberg F. The Role of Contrast-Enhanced Sonography for Radiofrequency Ablation of Liver Tumors. J. Ultrasound Med. 20:2001;517-523.
122. Unger E., Matsunaga T.O., Schumann P.A., Zutshi R. Microbubbles in molecular imaging and therapy. MedicaMundi. 47(1):2003;58-65.
123. ν-Integrins. Circulation. 107:2003;455-460.